Anti-human leukocyte antigen antibodies and development of graft failure after renal transplantation

Transplantation

Volumn 88, Issue 12, 2009, Pages 1399-1400

  Van Timmeren, Mirjan M ^a   Lems, Simon P M ^a   Hepkema, Bouke G ^a   Bakker, Stephan J L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HLA ANTIBODY; PROCALCITONIN; ALLOANTIBODY; HLA ANTIGEN;

CREATININE CLEARANCE; FOLLOW UP; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; CHRONIC KIDNEY FAILURE; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; NOTE;

GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION;

EID: 74049144875     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bc3ef0     Document Type: Letter

References (3)

1. Lachmann N, Terasaki PI, Budde K, et al. Anti-human leukocyte antigen and donor-specific antibodies detected byluminex post-transplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009; 87: 1505.
2. Van Ree RM, de Vries APJ, Oterdoom LH, et al. Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation. Transplantation 2009; 88: 279.
3. Gebel HM, Bray RA. Sensitization and sensitivity: Defining the unsensitized patient. Transplantation 2000; 69: 1370.